Horseadvice.com

Site Menu:

Horseadvice.com

Join Us!

Horse Care

Equine Diseases

Training and Behavior

Reproduction

Medications

Reference Material

This is an archived Horseadvice.com Discussion. The parent article and menus are available on the navigation menu below:
HorseAdvice.com » Diseases of Horses » Nervous System » Incoordination, Weakness, Spasticity, Tremors » EHV-1 (Equine Herpes) Myeloencephalopathy »
  Discussion on Research Study: Valacyclovir Oral Dosing
Author Message
Moderator:
DrO

Posted on Wednesday, Aug 26, 2009 - 3:21 am:

Can valcyclovir help prevent herpes encephalopathy? Case reviews are mixed on this question. This study suggests the problem may be variable absorption and that higher doses might overcome this problem.
DrO

J Vet Pharmacol Ther. 2009 Jun;32(3):207-12.
Multiple oral dosing of valacyclovir in horses and ponies.

Garré B, Baert K, Nauwynck H, Deprez P, DE Backer P, Croubels S.

Department of Pharmacology, Department of Internal Medicine, Faculty of Veterinary Medicine, Ghent University, Belgium.

The aim of the current study was to investigate whether multiple oral dosing of valacyclovir could result in plasma concentrations exceeding the EC(50)-value of acyclovir against equine herpesvirus 1 (EHV1) during the majority of the treatment period. Additionally, we wanted to determine the concentration of acyclovir in nasal mucus and cerebrospinal fluid (CSF). Valacyclovir was administered to four horses and two ponies, three times daily, at a dosage of 40 mg/kg, for four consecutive days. Blood was collected prior to each administration and 1 h after dosing. Nasal mucus samples and CSF were collected once during treatment; 1 h after the last administration. This dosage regimen resulted in plasma concentrations that were higher than the EC(50)-value of 1.7 mug/mL, i.e. EC(50) of an isolate highly susceptible to acyclovir, for 80% of the treatment period; and higher than the EC(50)-value of 3.0 mug/mL, i.e. EC(50) of an isolate less susceptible to acyclovir, for 60% of the treatment period. Concentration in nasal mucus samples and CSF was 0.36-1.17 mug/mL and 0.11-0.23 mug/mL, respectively. This study illustrates that multiple dosing of valacyclovir may result in a therapeutic benefit as plasma concentrations could be maintained above the EC(50)-value of acyclovir against EHV1 for more than 50% of the treatment period. Acyclovir could be detected in both nasal mucus samples and CSF. However, these concentrations were lower than the EC(50).
Home Page | Top of Page | Join Us!
Horseadvice.com
is The Horseman's Advisor
Helping Thousands of Equestrians, Farriers, and Veterinarians Every Day
All rights reserved, © 1997 -
Horseadvice.com is a BBB Accredited Business. Click for the BBB Business Review of this Horse Training in Stokesdale NC